OMDM-1 is primarily utilized in research settings, particularly in the study of endocannabinoid systems. It acts as a selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), which is responsible for the breakdown of endocannabinoids like anandamide. By inhibiting FAAH, OMDM-1 helps to increase the levels of anandamide in the body, allowing researchers to study its effects on pain, inflammation, and mood regulation. This compound is valuable in preclinical studies aimed at understanding the therapeutic potential of modulating the endocannabinoid system for conditions such as chronic pain, anxiety, and neurodegenerative diseases. Additionally, OMDM-1 is used to explore the role of endocannabinoids in various physiological processes, including appetite control and immune response. Its application is largely confined to laboratory research, contributing to the development of potential pharmacological treatments targeting the endocannabinoid pathway.